Is statistical re-evaluation of hemolymphoreticular neoplasms from aspartame studies valid?
Toxicol Sci
.
2023 Sep 28;195(2):143-144.
doi: 10.1093/toxsci/kfad070.
Authors
Susan A Elmore
1
,
Jerold E Rehg
2
,
Trenton R Schoeb
3
,
Jeffrey I Everitt
4
,
Brad Bolon
5
Affiliations
1
ElmorePathology, LLC, Chapel Hill, North Carolina, USA.
2
Department of Pathology, Emeritus, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
3
Department of Genetics and Animal Resources Program, University of Alabama at Birmingham, Birmingham, Alabama, USA.
4
Department of Pathology, Duke University School of Medicine, Durham, North Carolina, USA.
5
GEMpath, Inc., Longmont, Colorado, USA.
PMID:
37767919
PMCID:
PMC10535777
DOI:
10.1093/toxsci/kfad070
No abstract available